Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 8Active not recruiting 4Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 28Stomach Neoplasms 22Pancreatic Neoplasms 15Colonic Neoplasms 14Rectal Neoplasms 9Esophageal Neoplasms 9Adenocarcinoma Of Esophagus 8Lymphoma, Large B-Cell, Diffuse 7Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Cholangiocarcinoma 4Ovarian Neoplasms 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Lymphoma, Follicular 2Hepatoblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Colorectal Cancer 1Triple Negative Breast Neoplasms 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Rectal Diseases 1

Interventions

pembrolizumab 35Cisplatin 12Paclitaxel 9lenvatinib 7Carboplatin 6belzutifan 5Saline Solution 4Pemetrexed 4Oxaliplatin 4Fluorouracil 4Leucovorin 3Etoposide 3Docetaxel 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3olaparib 2enfortumab vedotin 2durvalumab 2Surgical Procedures, Operative 2Radiotherapy 2Levoleucovorin 2Glucose 2Capecitabine 2Bevacizumab 2zanidatamab 1tislelizumab 1sacituzumab govitecan 1liposomal doxorubicin 1enzalutamide 1balstilimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Parkinson Disease 4, Autosomal Dominant Lewy Body × Oxaliplatin × Clear all
NCT05239741 2026-05-22

MK-3475-C66

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
100 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colorectal Neoplasms

NCT05152147 2026-05-19

HERIZON-GEA-01

Jazz Pharmaceuticals

Phase 3 Active not recruiting
920 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

NCT04210115 2026-05-13

KEYNOTE 975

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
703 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT04949256 2025-12-15

MK-7902-014

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
864 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡